Cargando…
Comprehensive Genomic Profiling in the Management of Ovarian Cancer—National Results from Croatia
Today, in the era of precision medicine, the determination of genomic instability or other potentially targetable mutations, along with BRCA 1 and BRCA 2, is a crucial component of the diagnosis and treatment management of advanced ovarian cancer. Advanced technologies such as next-generation sequen...
Autores principales: | Čerina, Dora, Matković, Višnja, Katić, Kristina, Lovasić, Ingrid Belac, Šeparović, Robert, Canjko, Ivana, Bajić, Žarko, Vrdoljak, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9322425/ https://www.ncbi.nlm.nih.gov/pubmed/35887672 http://dx.doi.org/10.3390/jpm12071176 |
Ejemplares similares
-
Precision Oncology in Metastatic Uterine Cancer; Croatian First-Year Experience of the Comprehensive Genomic Profiling in Everyday Clinical Practice
por: Čerina, Dora, et al.
Publicado: (2021) -
Olaparib Outcomes in Patients with BRCA 1-2 Mutated, Platinum-Sensitive, Recurrent Ovarian Cancer in Croatia: A Retrospective Noninterventional Study
por: Majić, Ana, et al.
Publicado: (2020) -
Real-World Efficacy and Safety of Bevacizumab in the First-Line Treatment of Metastatic Cervical Cancer: A Cohort Study in the Total Population of Croatian Patients
por: Čerina, Dora, et al.
Publicado: (2021) -
The Challenges and Opportunities of the Implementation of Comprehensive Genomic Profiling in Everyday Clinical Practice with Non-Small Cell Lung Cancer: National Results from Croatia
por: Čerina, Dora, et al.
Publicado: (2023) -
COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
por: Vrdoljak, Eduard, et al.
Publicado: (2021)